Wavelength Pharmaceuticals is the standalone API company of choice for pharmaceutical industry leaders that require advanced API solutions to gain sustainable, competitive advantages.
Introducing Wavelength Pharmaceuticals
We are on the same wavelength. A partner in tune with the results required to better support your needs. Find out why pharmaceutical industry leaders partner with Wavelength Pharmaceuticals to acquire best-in-class solutions.
Wavelength, a standalone API company, offers differentiated solutions that support your market leadership position. We provide a strategic alliance that is “customized” to include the products and service you require to go to market, such as Active Pharmaceutical Ingredients (APIs), Finished Dosage Forms (FDFs), Dossiers, and co-development partnerships.
Always in Full Compliance
Founded in Israel in 1987 and USFDA approved since 1996, Wavelength employs a highly skilled team with all the expertise you require to advance your products to market, now, and well into the future. Ask us about our exemplary track record in products that comply with the highest regulatory requirements of leading health authorities, such as the USFDA, EU authorities, PMDA, TGA, ANVISA, and COFEPRIS. Visit us and see why our cGMP-compliant facility is a first-class operation recognized for excellence in safety, and environmental stewardship.